Unknown

Dataset Information

Transient partial response of poorly-differentiated thyroid carcinoma to sunitinib treatment: A case report.


ABSTRACT: Thyroid cancer is the most common endocrine malignancy, with an increasing prevalence worldwide. Poorly-differentiated thyroid cancer (PDTC) is relatively rare and its prognosis is poor. To date, no ideal treatment strategy is available for patients with advanced recurrent PDTC, particularly for patients in crisis. However, partial success in treating thyroid cancer has been achieved with targeted therapy, and advances made in understanding the molecular biology of the tumor. The current study describes the case of a patient diagnosed with PDTC following presentation with hoarseness, orthopnea, and a large right neck mass. A transient partial response to sunitinib malate treatment was achieved for >3 months. In addition, the current study reviewed the relevant literature and discussed the

SUBMITTER: Duo LJ 

PROVIDER: S-EPMC4487152 | biostudies-literature | 2015 Jul

REPOSITORIES: biostudies-literature